Jérôme Poupiot

881 total citations
21 papers, 668 citations indexed

About

Jérôme Poupiot is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Jérôme Poupiot has authored 21 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Genetics and 5 papers in Oncology. Recurrent topics in Jérôme Poupiot's work include Muscle Physiology and Disorders (15 papers), Virus-based gene therapy research (9 papers) and Calpain Protease Function and Regulation (5 papers). Jérôme Poupiot is often cited by papers focused on Muscle Physiology and Disorders (15 papers), Virus-based gene therapy research (9 papers) and Calpain Protease Function and Regulation (5 papers). Jérôme Poupiot collaborates with scholars based in France, United Kingdom and United States. Jérôme Poupiot's co-authors include Isabelle Richard, Marc Bartoli, Olivier Danos, Carinne Roudaut, Françoise Fougerousse, Evelyne Gicquel, Fatima Amor, Fanny Noulet, David Israeli and Laurence Suel and has published in prestigious journals such as Circulation, Nature Communications and PLoS ONE.

In The Last Decade

Jérôme Poupiot

20 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jérôme Poupiot France 14 589 210 123 118 113 21 668
Kristin N. Heller United States 14 569 1.0× 180 0.9× 137 1.1× 80 0.7× 51 0.5× 20 644
Charis L. Himeda United States 19 894 1.5× 318 1.5× 186 1.5× 47 0.4× 44 0.4× 25 995
Patrick Frosk Canada 10 495 0.8× 81 0.4× 140 1.1× 119 1.0× 74 0.7× 18 618
Hollie A. Harper United States 7 895 1.5× 422 2.0× 186 1.5× 83 0.7× 75 0.7× 10 1.0k
Diane E. Frank United States 9 529 0.9× 106 0.5× 96 0.8× 35 0.3× 155 1.4× 15 716
Kinga I. Gawlik Sweden 16 716 1.2× 82 0.4× 74 0.6× 66 0.6× 154 1.4× 22 832
Sofia Benkhelifa‐Ziyyat France 12 657 1.1× 261 1.2× 56 0.5× 76 0.6× 101 0.9× 22 850
Laurence Suel France 16 652 1.1× 94 0.4× 162 1.3× 166 1.4× 258 2.3× 18 741
Marybeth Camboni United States 11 406 0.7× 166 0.8× 102 0.8× 67 0.6× 50 0.4× 14 478
Stuart G. Beattie Spain 10 640 1.1× 306 1.5× 93 0.8× 223 1.9× 24 0.2× 16 797

Countries citing papers authored by Jérôme Poupiot

Since Specialization
Citations

This map shows the geographic impact of Jérôme Poupiot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Poupiot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Poupiot more than expected).

Fields of papers citing papers by Jérôme Poupiot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Poupiot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Poupiot. The network helps show where Jérôme Poupiot may publish in the future.

Co-authorship network of co-authors of Jérôme Poupiot

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Poupiot. A scholar is included among the top collaborators of Jérôme Poupiot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Poupiot. Jérôme Poupiot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gicquel, Evelyne, Jérôme Poupiot, Sonsoles Campuzano, et al.. (2025). Transgene-induced cardiotoxicity in high-dose AAV gene transfer. Molecular Therapy.
2.
Suel, Laurence, et al.. (2024). An engineered AAV targeting integrin alpha V beta 6 presents improved myotropism across species. Nature Communications. 15(1). 7965–7965. 10 indexed citations
3.
Bourg, Nathalie, Jérôme Poupiot, Karine Charton, et al.. (2022). Dlk1-Dio3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in Duchenne muscular dystrophy. Life Science Alliance. 6(1). e202201506–e202201506. 9 indexed citations
4.
Spinazzi, Marco, Jérôme Poupiot, Julien Cassereau, et al.. (2021). Late-onset camptocormia caused by a heterozygous in-frame CAPN3 deletion. Neuromuscular Disorders. 31(5). 450–455. 5 indexed citations
5.
Vissing, John, Julia R. Dahlqvist, Carinne Roudaut, et al.. (2020). A single c.1715G>C calpain 3 gene variant causes dominant calpainopathy with loss of calpain 3 expression and activity. Human Mutation. 41(9). 1507–1513. 10 indexed citations
6.
Poupiot, Jérôme, Helena Costa Verdera, Romain Hardet, et al.. (2019). Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle. Molecular Therapy — Methods & Clinical Development. 15. 83–100. 19 indexed citations
7.
Rocha, Sylvie Da, Jérémy Bigot, Fanny Onodi, et al.. (2019). Temporary Reduction of Membrane CD4 with the Antioxidant MnTBAP Is Sufficient to Prevent Immune Responses Induced by Gene Transfer. Molecular Therapy — Methods & Clinical Development. 14. 285–299. 9 indexed citations
8.
Israeli, David, Jérémie Cosette, Guillaume Corre, et al.. (2019). An AAV-SGCG Dose-Response Study in a γ-Sarcoglycanopathy Mouse Model in the Context of Mechanical Stress. Molecular Therapy — Methods & Clinical Development. 13. 494–502. 21 indexed citations
9.
Israeli, David, Jérôme Poupiot, Fatima Amor, et al.. (2016). Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies. Scientific Reports. 6(1). 28097–28097. 33 indexed citations
10.
Poupiot, Jérôme, Aleksandar Zocevic, Fatima Amor, et al.. (2015). Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies. Human Molecular Genetics. 24(17). 4916–4932. 50 indexed citations
11.
Boisgérault, Florence, et al.. (2013). Prolonged Gene Expression in Muscle Is Achieved Without Active Immune Tolerance Using MicrorRNA 142.3p-Regulated rAAV Gene Transfer. Human Gene Therapy. 24(4). 393–405. 45 indexed citations
12.
Vignier, Nicolas, Fatima Amor, Paul Fogel, et al.. (2013). Distinctive Serum miRNA Profile in Mouse Models of Striated Muscular Pathologies. PLoS ONE. 8(2). e55281–e55281. 89 indexed citations
13.
14.
Poupiot, Jérôme, Jérôme Ausseil, & Isabelle Richard. (2010). Methods for Noninvasive Monitoring of Muscle Fiber Survival with an AAV Vector Encoding the mSEAP Reporter Gene. Methods in molecular biology. 709. 63–74. 2 indexed citations
15.
Bartoli, Marc, Jérôme Poupiot, Françoise Fougerousse, et al.. (2007). AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not α-sarcoglycan deficiency. Gene Therapy. 14(9). 733–740. 68 indexed citations
16.
Danièle, Nathalie, Hanns Lochmüller, Marina Mora, et al.. (2007). A third of LGMD2A biopsies have normal calpain 3 proteolytic activity as determined by an in vitro assay. Neuromuscular Disorders. 17(2). 148–156. 40 indexed citations
17.
Fougerousse, Françoise, Marc Bartoli, Jérôme Poupiot, et al.. (2006). Phenotypic Correction of α-Sarcoglycan Deficiency by Intra-arterial Injection of a Muscle-specific Serotype 1 rAAV Vector. Molecular Therapy. 15(1). 53–61. 55 indexed citations
18.
Bartoli, Marc, Jérôme Poupiot, Aurélie Goyenvalle, et al.. (2005). Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies. Gene Therapy. 13(1). 20–28. 29 indexed citations
19.
Bartoli, Marc, Carinne Roudaut, Samia Martin, et al.. (2005). Safety and Efficacy of AAV-Mediated Calpain 3 Gene Transfer in a Mouse Model of Limb-Girdle Muscular Dystrophy Type 2A. Molecular Therapy. 13(2). 250–259. 57 indexed citations
20.
Ginhoux, Florent, David‐Alexandre Gross, Jérôme Poupiot, et al.. (2004). HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. Molecular Therapy. 10(2). 279–289. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristin N. Heller Breakdown of academic impact, for papers by Charis L. Himeda Breakdown of academic impact, for papers by Patrick Frosk Breakdown of academic impact, for papers by Hollie A. Harper Breakdown of academic impact, for papers by Diane E. Frank Breakdown of academic impact, for papers by Kinga I. Gawlik Breakdown of academic impact, for papers by Sofia Benkhelifa‐Ziyyat Breakdown of academic impact, for papers by Laurence Suel Breakdown of academic impact, for papers by Marybeth Camboni Breakdown of academic impact, for papers by Stuart G. Beattie
Rankless by CCL
2026